-
21.
公开(公告)号:US20240196642A1
公开(公告)日:2024-06-13
申请号:US18342600
申请日:2023-06-27
Applicant: Samsung Display Co., Ltd.
Inventor: Seran Kim , Hoilim Kim , Saerom Park , Dongsun Yoo , Junyoung Lee
IPC: H10K50/805 , C07D405/04 , C07D405/10 , C07D409/10 , C07D409/14 , C07D421/04 , C07D421/10 , H10K50/15 , H10K50/16 , H10K85/60
CPC classification number: H10K50/805 , C07D405/04 , C07D405/10 , C07D409/10 , C07D409/14 , C07D421/04 , C07D421/10 , H10K50/15 , H10K50/16 , H10K85/636 , H10K85/657
Abstract: An opto-electronic device includes a first electrode, a second electrode facing the first electrode, a photoactive layer arranged between the first electrode and the second electrode, and an organic compound represented by Formula 1:
wherein a maximum absorption wavelength of the organic compound is in a range of about 490 nm to about 570 nm, and an oscillator strength (OSC) of the organic compound is in a range of about 0.8 to about 1.0.-
公开(公告)号:US20210257554A1
公开(公告)日:2021-08-19
申请号:US17152104
申请日:2021-01-19
Applicant: Universal Display Corporation
Inventor: Lichang ZENG , Suman LAYEK , Pierre-Luc T. BOUDREAULT , Zeinab ELSHENAWY , Gregg KOTTAS , Alexey Borisovich DYATKIN , Scott JOSEPH , Vadim ADAMOVICH , Chuanjun XIA , Ting-Chih WANG , Walter YEAGER
IPC: H01L51/00 , C09K11/06 , C09K11/02 , C07D409/10 , C07D251/24 , C07D421/10 , C07D409/04 , C07D405/10
Abstract: A composition of materials including a first compound having a structure according to Formula I
-
公开(公告)号:US09802907B2
公开(公告)日:2017-10-31
申请号:US14648664
申请日:2013-11-24
Inventor: Dongfang Shi , Changjin Fu , Jie Wu , Jun Liu
IPC: C07D293/06 , C07D421/10 , A61K31/381 , A61K33/04 , A61K31/41 , A61K31/4365 , A61K31/4439 , A61K31/496 , A61K31/5377 , C07D421/12 , C07D495/04
CPC classification number: C07D293/06 , A61K31/41 , A61K31/4365 , A61K31/4439 , A61K31/496 , A61K31/5377 , C07D421/10 , C07D421/12 , C07D495/04
Abstract: A 2-aryl selenazole compound and a pharmaceutical composition are disclosed, wherein the 2-aryl selenazole compound is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The 2-aryl selenazole compound has the activity of inhibiting xanthine oxidase. The compound or a pharmaceutically acceptable salt thereof can be applied in terms of preparing a drug used for prevention or treatment of hyperuricemia, gout, diabetic nephropathy, an inflammatory disease or a neurological disease.
-
公开(公告)号:US07482345B2
公开(公告)日:2009-01-27
申请号:US11602782
申请日:2006-11-21
Applicant: Meng-Hsin Chen , James B. Doherty , Robert Tynebor
Inventor: Meng-Hsin Chen , James B. Doherty , Robert Tynebor
IPC: A61K31/53 , A61K31/5025 , A61K31/4985 , A61K31/4375 , C07D401/06 , C07D401/12 , C07D401/10 , C07D401/14 , C07D421/06 , C07D421/10 , C07D421/12 , C07D421/14 , C07D487/04 , C07D471/04
CPC classification number: C07D455/02 , C07D471/04
Abstract: Compounds described by the chemical formula (I) or pharmaceutically acceptable salts thereof: are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.
Abstract translation: 由化学式(I)或其药学上可接受的盐描述的化合物是p38的抑制剂,可用于治疗炎症,例如治疗类风湿性关节炎,类风湿性脊椎炎,骨关节炎,痛风性关节炎和其他关节炎病症; 发炎关节,湿疹,牛皮癣或其他炎症皮肤病如晒伤; 炎症性眼病,包括结膜炎; 皮肤炎,疼痛等与炎症有关的病症。
-
公开(公告)号:US2856404A
公开(公告)日:1958-10-14
申请号:US59250756
申请日:1956-06-20
Applicant: EASTMAN KODAK CO
Inventor: BROOKER LESLIE G S , HESELTINE DONALD W
IPC: C07D231/26 , C07D239/60 , C07D261/12 , C07D277/36 , C07D413/10 , C07D417/04 , C07D417/10 , C07D417/14 , C07D421/10 , C09B23/01 , C09B23/10
CPC classification number: C07D413/10 , C07D231/26 , C07D239/60 , C07D261/12 , C07D277/36 , C07D417/04 , C07D417/10 , C07D417/14 , C07D421/10 , C09B23/0066 , C09B23/102
-
-
-
-